Absci Corporation

US$10.17As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:ABSIHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (17.74%)
Div yield —
ROE (57.72%)
Biotechnology
Beta (5Y) 2.19
PE TTM —
TSR TTM 137.62%
Mkt cap US$1.745B
ROIC (37.90%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$11
5.07%
(85.36%)
Hold 0|5|8|1|11
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.16
0.16
0.17
0.17
12.20%
3.19%
12.25%
(1.44%)
Revenue$M
113.9
117.0
113.5
115.2
0.45%
4.92%
0.60%
5.02%
Peers (US$1.745B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.448
(0.307)
(0.260)
EBIT/Intx
0.272
0.281
0.264
Own earn%
6.57
(22.72)
(21.65)
Sh yield%
21.92
31.63
33.24
Owners
Insiders/Inst%
11.26
79.79
Short interest%
4.47
SBC / revenue%
5.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
8–14
$1 testx
0.2
Incr. ROIC%
10